Citius Pharmaceuticals, Inc. (CTXR)

Price & Market Data

Price: $0.691

Daily Change: +$0.0174 / 2.52%

Daily Range: $0.66 - $0.709

Market Cap: $19,246,996

Daily Volume: 433,854

Performance Metrics

1 Week: -5.19%

1 Month: -18.58%

3 Months: -2.52%

6 Months: -34.09%

1 Year: -2.48%

YTD: -9.05%

About Citius Pharmaceuticals, Inc. (CTXR)

A concise report on Citius Pharmaceuticals, Inc. (CTXR). Price: 0.691, daily change: +$0.0174 / 2.52%. Market cap: 19,246,996. YTD performance and 1-month returns.

Company Details

Employees: 23

Sector: Health technology

Industry: Medical specialties

Country: United States

Details

Citius Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of critical care products. Its LYMPHIR, an FDA-approved product, is a targeted immunotherapy for the treatment of cutaneous T-cell lymphoma. The company's late-stage pipeline includes Mino-Lok, an antibiotic lock solution to treat patients with catheter-related bloodstream infections; Halo-Lido, a corticosteroid-lidocaine topical formulation to provide anti-inflammatory and anesthetic relief to persons suffering from hemorrhoids; and NoveCite, a mesenchymal stem cell therapy for the treatment of ARDS. Citius Pharmaceuticals, Inc. was founded in 2007 and is headquartered in Cranford, New Jersey.

Selected stocks

Veru Inc. (VERU)

Singularity Future Technology Ltd. (SGLY)

Cherry Hill Mortgage Investment Corporation (CHMI)

Fractyl Health, Inc. (GUTS)

Tenon Medical, Inc. (TNON)